Status:
TERMINATED
Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
Lead Sponsor:
University of California, San Francisco
Conditions:
Hepatitis C
Eligibility:
All Genders
Brief Summary
The purpose of this study is to determine if hepatitis C virus and influenza virus vaccine components can cross the placenta and stimulate an immune response in the fetus.
Detailed Description
The rate of mother-to-child transmission of hepatitis C virus (HCV) is only 5%, even though the level of fetal exposure to the virus during pregnancy is probably much higher. How can the fetus avoid i...
Eligibility Criteria
Inclusion
- pregnant women 18 years of age or older
- infants born to these women from this pregnancy
- hepatitis C virus antibody and RNA positive (for study group)
- hepatitis C virus antibody and RNA negative (for control group)
Exclusion
- HIV infection
- hepatitis B infection
- plan to use cord blood for another purpose
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00810875
Start Date
April 1 2009
End Date
August 1 2010
Last Update
August 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco General Hospital, University of California, San Francisco
San Francisco, California, United States, 94110